Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Depreciation & Amortization (CF) (2016 - 2025)

MedWellAI (MWAI) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $2634.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 1316.13% to $2634.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3083.0, a 100.21% increase, with the full-year FY2025 number at $1058.0, changed N/A from a year prior.
  • Depreciation & Amortization (CF) was $2634.0 for Q4 2025 at MedWellAI, up from $2369.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q1 2023 to a low of -$2.2 million in Q2 2024.
  • A 5-year average of $272572.4 and a median of $403606.5 in 2022 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): tumbled 266.3% in 2024, then surged 1316.13% in 2025.
  • MedWellAI's Depreciation & Amortization (CF) stood at $424025.0 in 2021, then fell by 8.05% to $389901.0 in 2022, then skyrocketed by 91.26% to $745720.0 in 2023, then tumbled by 99.98% to $186.0 in 2024, then soared by 1316.13% to $2634.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Depreciation & Amortization (CF) are $2634.0 (Q4 2025), $2369.0 (Q3 2025), and -$1.1 million (Q2 2025).